comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists Comparative efficacy of glucagon-like peptide-1 receptor on in patients type 2 diabetes: a systematic review and network meta-analysis | Cardiovascular Diabetology Updated Ranking and Side Effects

Some services may be available virtually depending on Illinois regulations and your care plan, though in-person visits are typically recommended for lab work and evaluations

If an individual misreads the markings on the syringe (confusing units with milligrams, for example), they may accidentally inject several times the intended amount

Efficacy differs measurably in trials, with semaglutide showing up to about 15% average body weight reduction over extended study periods versus roughly 9% average weight loss for liraglutide at 12 months

Sadek is a Clinical Assistant Professor of Surgery at Rutgers-Robert Wood Johnson Medical School and a Fellow of the American College of Surgeons

Lyons SK, Hermann JM, Miller KM et al (2017) Use of adjuvant pharmacotherapy in type 1 diabetes: international comparison of 49,996 individuals in the prospective diabetes follow-up and T1D exchange registries

Journal of Clinical Oncology, 23(22), 5138-5147